prikaz prve stranice dokumenta Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
  Download
PDF 611.15 KB
Scientific paper - Original scientific paper
Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
Blood Cancer Journal, 11 (2021), 11; 189. https://doi.org/10.1038/s41408-021-00585-2
Lucijanić, Marko; Krečak, Ivan; Sorić, Ena; Sedinić, Martina; Sabljić, Anica; Derek, Lovorka; Jakšić, Ozren; Kušec, Rajko

Linked objects
COVID-19 | Virtual collection

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Lucijanić, M., Krečak, I., Sorić, E., Sedinić, M., Sabljić, A., Derek, L. ... Kušec, R. (2021). Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism. Blood Cancer Journal, 11. (11). doi: 10.1038/s41408-021-00585-2

Lucijanić, Marko, et al. "Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism." Blood Cancer Journal, vol. 11, no. 11, 2021. https://doi.org/10.1038/s41408-021-00585-2

Lucijanić, Marko, Ivan Krečak, Ena Sorić, Martina Sedinić, Anica Sabljić, Lovorka Derek, Ozren Jakšić and Rajko Kušec. "Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism." Blood Cancer Journal 11, no. 11 (2021). https://doi.org/10.1038/s41408-021-00585-2

Lucijanić, M., et al. (2021) 'Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism', Blood Cancer Journal, 11(11). doi: 10.1038/s41408-021-00585-2

Lucijanić M, Krečak I, Sorić E, Sedinić M, Sabljić A, Derek L, and sur.. Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism. Blood Cancer Journal [Internet]. 2021 November 29 [cited 2024 April 28];11(11). doi: 10.1038/s41408-021-00585-2

M. Lucijanić, et al., "Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism", Blood Cancer Journal, vol. 11, no. 11, November 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:424560. [Accessed: 28 April 2024]

Metadata
Title (english)Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
AuthorMarko Lucijanić
AuthorIvan Krečak
AuthorEna Sorić
AuthorMartina Sedinić
AuthorAnica Sabljić
AuthorLovorka Derek
AuthorOzren Jakšić
AuthorRajko Kušec
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleBlood Cancer Journal
Numberingvol. 11, no. 11, 189
e-ISSN2044-5385
DOIhttps://doi.org/10.1038/s41408-021-00585-2
URN:NBNurn:nbn:hr:105:424560
Publication2021-11-29
Document URLhttps://www.nature.com/articles/s41408-021-00585-2
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2022-03-01 08:32:57